UnitedHealth Group Incorporated

What they do

Through Optum, the company provides clinical expertise, technology, data analytics, pharmacy care, and health financial services to patients, providers, payers, employers, and governments. Through UnitedHealthcare, it offers a full range of health benefit plans for employers, individuals, seniors (Medicare), and economically disadvantaged populations (Medicaid). The four reportable segments are Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare.

Revenue drivers

• UnitedHealthcare — Generated $86.0 billion in revenue in Q2 2026, serving 48.5 million consumers; includes Employer & Individual, Medicare & Retirement, and Community & State plans.
• Optum — Generated $65.7 billion in revenue in Q2 2026, supporting more than 120 million consumers; includes Optum Health, Optum Insight, and Optum Rx.
• Optum Rx — Pharmacy care services business, part of Optum; contributed to Optum's overall earnings and is expected to deliver >$6.25 billion in adjusted operating earnings in 2026.
• Optum Health — Value-based care and population health business; expected to deliver >$2.275 billion in reported operating earnings in 2026.

Recent performance

In Q2 2026, UnitedHealth Group reported revenues of $112.0 billion and earnings from operations of $8.0 billion. GAAP diluted EPS was $6.04; adjusted EPS was $6.38. The medical cost ratio was 86.7%, with operating cost ratio of 12.7%. Cash flows from operations were $11.1 billion, and the debt-to-capital ratio was 41.2% as of June 30, 2026. Full-year 2025 revenue was $447.57 billion with net income of $12.06 billion.

Strategy

Management is focused on simplifying operations, improving affordability, and applying technology (including artificial intelligence) to create a higher-performing health system. The company is advancing value-based care, modernizing consumer and provider experiences, and making targeted investments in infrastructure and community support. A 2026 business realignment moved Optum Financial into Optum Insight to better respond to market opportunities. Recent actions include portfolio divestitures and a $400 million contribution to the United Health Foundation.

Risks

• Medical cost trends — Continued increases in medical costs could impact pricing, benefit design, and the medical cost ratio, which was 86.7% in Q2 2026.
• Regulatory changes — Changes in government programs (Medicare, Medicaid) and minimum medical loss ratio thresholds could affect revenue and operating margins.
• Competitive pressures — The commercial risk market remains highly competitive across small group, large group, and individual segments, affecting pricing and enrollment.
• Execution of strategic actions — The company's net portfolio divestitures and restructuring activities involve risks related to integration, operational disruption, and expected gains not materializing.

Outlook

For full-year 2026, management updated adjusted net earnings guidance to $19.50-$20.00 per share and reported EPS to $18.45-$18.95. They expect cash flows from operations of approximately $24 billion and share repurchases of at least $5 billion. The improved outlook reflects year-to-date performance and expected progress in controlling costs and enhancing affordability.